NeuroBo Pharmaceuticals Inc (NRBO)
3.10
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 10:58
NeuroBo Pharmaceuticals Shareholders Equity (Quarterly): 16.68M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 16.68M |
September 30, 2023 | 21.55M |
June 30, 2023 | 25.20M |
March 31, 2023 | 20.51M |
December 31, 2022 | 21.75M |
September 30, 2022 | 5.938M |
June 30, 2022 | 8.833M |
March 31, 2022 | 11.93M |
December 31, 2021 | 14.60M |
September 30, 2021 | 6.125M |
June 30, 2021 | 9.478M |
March 31, 2021 | 13.15M |
December 31, 2020 | 7.203M |
September 30, 2020 | 9.506M |
June 30, 2020 | 12.34M |
March 31, 2020 | 7.74M |
December 31, 2019 | 12.29M |
Date | Value |
---|---|
September 30, 2019 | -1.025M |
June 30, 2019 | 1.964M |
March 31, 2019 | 4.446M |
December 31, 2018 | -13.29M |
September 30, 2018 | 10.85M |
June 30, 2018 | 15.05M |
March 31, 2018 | 20.82M |
December 31, 2017 | 3.941M |
September 30, 2017 | 9.949M |
June 30, 2017 | 17.73M |
March 31, 2017 | 25.30M |
December 31, 2016 | 20.63M |
September 30, 2016 | 26.99M |
June 30, 2016 | -15.96M |
March 31, 2016 | -0.594M |
December 31, 2015 | -12.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.025M
Minimum
Sep 2019
25.20M
Maximum
Jun 2023
11.88M
Average
11.93M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Conmed Corp | 834.22M |
Eli Lilly and Co | 10.77B |
Vanda Pharmaceuticals Inc | 544.91M |
Alaunos Therapeutics Inc | 6.307M |
Relmada Therapeutics Inc | 85.36M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 22.78M |
Total Liabilities (Quarterly) | 6.096M |